These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11366693)
21. Amprenavir approved. AIDS Patient Care STDS; 1999 Jul; 13(7):438. PubMed ID: 10870601 [No Abstract] [Full Text] [Related]
22. Amprenavir made available through early access program. AIDS Patient Care STDS; 1998 Dec; 12(12):939-40. PubMed ID: 11362067 [No Abstract] [Full Text] [Related]
23. Clinical pharmacology and pharmacokinetics of amprenavir. Sadler BM; Stein DS Ann Pharmacother; 2002 Jan; 36(1):102-18. PubMed ID: 11816239 [TBL] [Abstract][Full Text] [Related]
26. New drugs: amprenavir and abacavir. TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365435 [TBL] [Abstract][Full Text] [Related]
27. FDA notifications. New 600 mg tablet strength for darunavir is approved by FDA. AIDS Alert; 2008 Apr; 23(4):47. PubMed ID: 19253456 [No Abstract] [Full Text] [Related]
28. Lower dose of ritonavir approved for use with fosamprenavir. Sax PE AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004 [No Abstract] [Full Text] [Related]
29. FDA approval: darunavir. Sax PE AIDS Clin Care; 2006 Aug; 18(8):71. PubMed ID: 16906668 [No Abstract] [Full Text] [Related]
30. What they say about protease inhibitors. Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522 [TBL] [Abstract][Full Text] [Related]
31. A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience. Schooley RT; Clumeck N; Haubrich R; Thompson M; Danner SA; van Der Ende ME; Sereni D; Antunes F; Blake D; Myers RE; Tisdale M; Millard J; Mustafa N; Nacci P Antivir Ther; 2001 Jun; 6(2):89-96. PubMed ID: 11491421 [TBL] [Abstract][Full Text] [Related]
37. Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults. Sadler BM; Hanson CD; Chittick GE; Symonds WT; Roskell NS Antimicrob Agents Chemother; 1999 Jul; 43(7):1686-92. PubMed ID: 10390223 [TBL] [Abstract][Full Text] [Related]
38. FDA notifications. FDA OKs new pediatric dosing for darunavir. AIDS Alert; 2009 Feb; 24(2):22-4. PubMed ID: 19222149 [No Abstract] [Full Text] [Related]
39. Amprenavir (AGENERASE) oral solution: warning for some patients. AIDS Treat News; 2000 May; (342):3. PubMed ID: 12870457 [TBL] [Abstract][Full Text] [Related]
40. FDA notifications. FDA approves new formulation of Lexiva. AIDS Alert; 2007 Aug; 22(8):90-1. PubMed ID: 17768778 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]